Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. (2016)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002037
PubMed Identifier: 27299522
Publication URI: http://europepmc.org/abstract/MED/27299522
Type: Journal Article/Review
Volume: 13
Parent Publication: PLoS medicine
Issue: 6
ISSN: 1549-1277